Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study. [PDF]
Lancet Reg Health EurBach P +5 more
europepmc +1 more source
Prescription psychostimulants, atomoxetine and the risk of psychosis in adults with history of psychosis: a population-based cohort study. [PDF]
Transl PsychiatryBach P +5 more
europepmc +1 more source
Pharmacological management of attention deficit hyperactivity disorder in adults. [PDF]
Aust PrescrSuetani S, Hull J, Scott JG.
europepmc +1 more source
Combined amphetamine and cocaine abuse caused mesencephalic ischemia in a 16-year-old boy - Due to vasospasm? [PDF]
, 2000 Brandt, T. +2 more
core +1 more source
The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000-2025. [PDF]
Drug Alcohol Depend RepDarke S +4 more
europepmc +1 more source
Using a controlled stimulant to treat cocaine use disorder in the setting of attention deficit/hyperactivity disorder: a case study. [PDF]
Front PsychiatryBozman M +4 more
europepmc +1 more source
Disruption of Dopamine Homeostasis by Psychostimulants. [PDF]
Mol NeurobiolTorres J +3 more
europepmc +1 more source
Functional neuroanatomy of dopaminergic arousal systems: implications for the wake-promoting effect of psychostimulants, with particular reference to modafinil. [PDF]
Front NeuroanatSzabadi E.
europepmc +1 more source
Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder. [PDF]
Obstet GynecolXu KY +11 more
europepmc +1 more source
Post-discharge use of opioids, psychostimulants, and treatment medications following residential opioid discontinuation with NET Device™ monotherapy. [PDF]
Front PsychiatryGreenwald MK, Arfken CL, Winston JR.
europepmc +1 more source